Bromo 2,3,4,6-Tetra-O-acetyl-α-D-mannopyranoside (CAS 13242-53-0)

Bromo 2,3,4,6-Tetra-O-acetyl-α-D-mannopyranoside, a derivatized mannose derivative, has become a pivotal tool in glycobiology research, particularly in investigations focusing on carbohydrate chemistry and glycan-mediated processes. Its mechanism of action primarily revolves around its structural resemblance to natural mannose moieties, enabling its utilization as a molecular probe for studying carbohydrate-protein interactions. This compound serves as a substrate analog for enzymes involved in mannose metabolism, facilitating the elucidation of enzymatic mechanisms and kinetics through biochemical assays and structural studies. Furthermore, researchers have exploited its chemical properties to synthesize glycoconjugates and glycomimetics with tailored structures, enabling the interrogation of glycan-mediated signaling pathways and cellular processes. In addition, this compound has found applications in glycan microarray technology, where it serves as a key component for immobilizing glycan probes onto solid surfaces, allowing for high-throughput screening of glycan-binding proteins and receptors. Moreover, its utility extends to the field of carbohydrate-based drug discovery, where it aids in the development of vaccine candidates by facilitating the synthesis of glycan mimetics for structure-activity relationship studies and immunological investigations. Through its versatile applications, Bromo 2,3,4,6-Tetra-O-acetyl-α-D-mannopyranoside continues to advance our understanding of carbohydrate biology and pave the way for innovative research strategies aimed at unraveling the roles of glycans in various biological processes.